Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-27 12:13 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, India, Tax & Budget, Asia Pacific
--------------------------------------------------------------------
Snippet:
India's Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion, including debt.
--------------------------------------------------------------------